C M BIDWELL & ASSOCIATES LTD - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 291 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
C M BIDWELL & ASSOCIATES LTD ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$38,247
-2.6%
1,709
+19.8%
0.03%
-3.7%
Q1 2024$39,257
+10626.0%
1,427
+11791.7%
0.03%
Q4 2023$366
-77.3%
12
-76.5%
0.00%
-100.0%
Q3 2023$1,613
-22.5%
510.0%0.00%
-50.0%
Q2 2023$2,080
+9.4%
510.0%0.00%
+100.0%
Q1 2023$1,901
+6.9%
510.0%0.00%0.0%
Q4 2022$1,779
+77.9%
51
+325.0%
0.00%0.0%
Q3 2022$1,0000.0%120.0%0.00%0.0%
Q2 2022$1,0000.0%120.0%0.00%0.0%
Q1 2022$1,000120.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders